BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 10751508)

  • 21. Cholinergic agonists decrease quantal output at the frog neuromuscular junction by targeting a calcium channel blocked by omega-conotoxin.
    Van der Kloot W; Molgó J; Naves LA
    Pflugers Arch; 1997 Nov; 434(6):735-41. PubMed ID: 9306006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitivity of the motor endplate to carbachol in the presence of sulfhydryl reagents].
    Bravo C; Sobrino JA; Ortiz J; Comas MD; García-Baro JA; del Riego T
    Rev Esp Fisiol; 1985 Mar; 41(1):5-10. PubMed ID: 4001543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in miniature endplate potential frequency during repetitive nerve stimulation in the presence of Ca2+, Ba2+, and Sr2+ at the frog neuromuscular junction.
    Zengel JE; Magleby KL
    J Gen Physiol; 1981 May; 77(5):503-29. PubMed ID: 6262429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency and amplitude gradients of spontaneous release along the length of the frog neuromuscular junction.
    Robitaille R; Tremblay JP
    Synapse; 1989; 3(4):291-307. PubMed ID: 2568018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etomidate evokes synaptic vesicle exocytosis without increasing miniature endplate potentials frequency at the mice neuromuscular junction.
    Valadão PA; Naves LA; Gomez RS; Guatimosim C
    Neurochem Int; 2013 Nov; 63(6):576-82. PubMed ID: 24044896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels.
    Pardo NE; Hajela RK; Atchison WD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1009-20. PubMed ID: 16982704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mg++ antagonism of a prejunctional opiate receptor mediated effect at the frog neuromuscular junction.
    Durham HD; Frank GB
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):72-82. PubMed ID: 6295295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
    Rang HP; Rylett RJ
    Br J Pharmacol; 1984 Mar; 81(3):519-31. PubMed ID: 6141831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of aminoglycoside antibiotics on the neuromuscular junction: Part I.
    Yamada S; Kuno Y; Iwanaga H
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):130-8. PubMed ID: 3699939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple actions of beta-bungarotoxin on acetylcholine release at amphibian motor nerve terminals.
    Alderdice MT; Volle RL
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Apr; 316(2):126-30. PubMed ID: 6972488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in miniature end-plate currents due to high potassium and calcium at the frog neuromuscular junction.
    Glavinović MI
    Synapse; 1988; 2(6):636-43. PubMed ID: 3264941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of alteration of nerve terminal Ca2+ regulation on increased spontaneous quantal release of acetylcholine by methyl mercury.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):55-65. PubMed ID: 3376114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hexamethonium- and methyllycaconitine-induced changes in acetylcholine release from rat motor nerve terminals.
    Tian L; Prior C; Dempster J; Marshall IG
    Br J Pharmacol; 1997 Nov; 122(6):1025-34. PubMed ID: 9401765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrical exploration of acetylcholine receptors.
    Katz B
    Postgrad Med J; 1981; 57 Suppl 1():84-8. PubMed ID: 6272255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temperature dependence of carbachol-induced modulation of miniature end-plate potential frequency in rats.
    Nikolsky EE; Strunsky EG; Vyskocil F
    Brain Res; 1991 Sep; 560(1-2):354-6. PubMed ID: 1760744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-uniform responses to Ca2+ along the frog neuromuscular junction: effects on the probability of spontaneous and evoked transmitter release.
    Robitaille R; Tremblay JP
    Neuroscience; 1991; 40(2):571-85. PubMed ID: 1674115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The continual administration of neostigmine and the neuromuscular junction.
    Gillies JD; Allen J
    Proc Aust Assoc Neurol; 1976; 13():149-53. PubMed ID: 1029001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-bungarotoxin selectively inhibits stimulus-bound repetition in isolated frog sympathetic ganglion.
    Minker E; Blazsó G; Gerö L
    Acta Physiol Hung; 1984; 64(1):81-9. PubMed ID: 6091409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is the presynaptic action of carbocholine related to the activation of the postsynaptic membrane?].
    Volkova IN; Nikol'skiĭ EE; Giniatullin RA
    Biull Eksp Biol Med; 1981 Apr; 91(4):393-6. PubMed ID: 7260354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.